维普中文期刊产品整合服务
13篇 您的检索式:作者名="Eltze M"
    题名 作者 年代 出处 被引量
1Expression and prognostic relevance of endothelin-B receptor in vulvar cancer 显示文摘Eltze E Bertolin M Korsching E 2007Oncology Reports2007,18,:1
2Urapidil and some analogs with high affinities for serolonin-lA and α1-adrenoceptor binding sites show potent hypotensive activity upon central administration显示文摘Sanders KH Beller KD Eltze M 1989Current Opinion in Cardiology1989,4,4:1
3External ATP antagonises the effect of potassium channel opener in guinea-Pig ventricular Papillary muscle显示文摘Bott A Eltze M Illes P 1992Eur J Pharmacol1992,213,:1
4Multiple mechanisms of action :the pharmacological profile of budipine显示文摘ELTZE M 1999J Neural Transm Suppl1999,56,:1
5Suicide probability scale andits utility with adolescent psychiatric patients 显示文摘ELTZ M EVANS AS CELIO M et el 2007Child Psych2007,38,1:1
6Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition显示文摘Klein T Eltze M Grebe T 2007Cardiovasc Res2007,75,:1
7Functional characterization of muscarinic autoreceptors in rat and human neocortex显示文摘Stoll C Eltze M Lambrecht G 2009J Neu rochem2009,110,3:1
8Suicide probability scale and its utility with adolescent psychiatric patient显示文摘Eltz M Evans A S Celio M 2007Child Psychiatry and Human Development2007,38,1:1
9Suicide Probability Scale and its u- tility with adolescent psychiatric patients显示文摘Eltz M Evans A S Celio M 2007Child Psychiatry and Human Development2007,38,1:1
10In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor 显示文摘Bundschuh D S Eltze M Barsig J 2001J Pharmacol Exp Ther2001,297,1:1
11In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor 显示文摘Bundschuh DS Eltze M Barsig J 2001J Pharmacol Exp Ther2001,297,1:1
12Suicide probability scale and its utility with adolescent psychiatric patients显示文摘Eltz M Evans A S Celio M 2007Child Psychiatry and Human Develo Pment2007,38,1:1
13儿童持续性部分性癫痫的诊断算法显示文摘总结一组持续性部分性癫痫(Epilepsia partialis continua,EPC)患儿的特点,并提出一种整合关键鉴别诊断的诊断算法。对2002年—2019年在三级儿科神经病学中心就诊的EPC患儿进行分析。54例患儿符合EPC诊断标准。中位发病年龄为7岁(0.6~15岁),中位随访时间为4.3年(0.2~16年)。其中,诊断为Rasmussen脑炎(Rasmussen encephalitis,RE)30例(56%),线粒体疾病12例(22.2%),磁共振成像(MRI)阳性病灶相关局灶性癫痫6例(11.1%),诊断不明5例(9%)。线粒体疾病患儿更早出现EPC,EPC发病年龄每增加一年,诊断线粒体疾病的几率降低26%(P=0.02)。EPC发作前存在发育问题(OR=22,P<0.001),EPC发作前无癫痫发作(OR=22,P<0.001), EEG提示双侧半球慢波(OR 26,P<0.001),以及脑脊液(CSF)蛋白水平升高(OR=16)均预示着线粒体疾病。30例RE患儿中有18例(60%)出现EPC发作时,MRI提示明显不对称或一侧半球萎缩,其余患儿出现的中位时间则在EPC发作后6个月(3~15个月)。首选诊断检查为头部MRI。一侧半球萎缩结合临床表现及脑电图改变的偏侧性,提示诊断为RE。对于初次扫描时不能诊断为RE,但临床和影像学表现提示RE的儿童,建议每6个月重复影像学检查以排查进行性一侧半球皮质萎缩,并应考虑脑活检,鞘内炎症的证据(寡克隆带和新蝶呤升高)可为佐证。对于存在双侧半球源性EPC的患儿,建议进行快速DNA聚合酶γ(POLG)基因检测,如为阴性,则应提取外周血DNA进行mtDNA测序及全外显子组测序。线粒体病所致EPC患儿表现出与RE和结构性癫痫不同的临床特征。这一针对EPC患儿的诊断算法有助于进行针对性检查并及时诊断。Snehal Surana Thomas Rossor Yael Hacohen Hassell J Boyd S D’Arco F Aylett S Bhate S Carr L Das K DeVile C Eltze C Hemingway C Kaliakatsos M O’Callaghan F Prabhakar P Robinson R Varadkar S Helen Cross J Hacohen Y 陈晨(译) 慕洁(审) 2021癫痫杂志2021,7,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费